Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.29 - $5.97 $57,691 - $80,284
13,448 New
13,448 $60,000
Q2 2023

Aug 14, 2023

SELL
$5.66 - $7.59 $158,032 - $211,920
-27,921 Reduced 22.29%
97,323 $628,000
Q1 2023

May 15, 2023

BUY
$7.31 - $11.18 $915,533 - $1.4 Million
125,244 New
125,244 $944,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $380,517 - $708,480
66,524 Added 51.22%
196,406 $2.09 Million
Q1 2022

May 16, 2022

BUY
$7.46 - $14.14 $968,919 - $1.84 Million
129,882 New
129,882 $1.27 Million
Q3 2021

Nov 15, 2021

SELL
$14.85 - $21.34 $2.59 Million - $3.72 Million
-174,428 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $3.52 Million - $5.96 Million
174,428 New
174,428 $3.84 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.